Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes. 1984

N O'Hara, and O E Brodde

In intact human lymphocytes the properties of (+/-)- and (-)-125iodocyanopindolol (ICYP) binding to beta 2-adrenoceptors were investigated. Binding of both ligands was in concentrations ranging from 10-200 pM saturable resulting in identical Bmax-values (about 550-650 specific ICYP binding sites/cell); the KD-value of (-)-ICYP (14.8 +/- 0.1 pM, N = 3), however, was about two times lower than that of (+/-)-ICYP (26.5 +/- 2.5 pM, N = 3). Irrespective of the ligand used alprenolol, betaxolol, ICI 118,551 and isoprenaline inhibited binding with identical KI-values. Binding was stereospecific, since the (+)-isomers of alprenolol and isoprenaline were about 50 times less potent in inhibiting binding than their respective (-)-isomers. In concentrations greater than 250 pM both ligands labeled a second class of binding sites in a non-saturable manner. These low affinity sites showed no stereospecificity; they may be related to unspecific uptake of the ligands into the cell. In kinetic experiments biphasic dissociation reactions were obtained for (+/-)- as well as (-)-ICYP; for both ligands the ratio fast/slow dissociating component was 40/60. It is concluded, that at low receptor concentrations (2.5-5 pmoles/l in the present study) the contribution of the (+)-isomer of ICYP to binding of the racemic ligand can be neglected. Thus, at low receptor concentrations both (+/-) and (-)-ICYP exhibit identical binding properties to beta 2-adrenoceptors in intact human lymphocytes.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000526 Alprenolol One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent. 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol,Alfeprol,Alpheprol,Alprenolol Hydrochloride,Aptin,Aptin-Duriles,Aptina,Aptine,H-56-28,Aptin Duriles,AptinDuriles,H 56 28,H5628

Related Publications

N O'Hara, and O E Brodde
September 1984, The Journal of pharmacy and pharmacology,
N O'Hara, and O E Brodde
January 1990, British journal of clinical pharmacology,
N O'Hara, and O E Brodde
November 1980, British journal of clinical pharmacology,
N O'Hara, and O E Brodde
January 1993, Archives internationales de pharmacodynamie et de therapie,
N O'Hara, and O E Brodde
November 1987, British journal of pharmacology,
N O'Hara, and O E Brodde
May 1984, Biochemical and biophysical research communications,
N O'Hara, and O E Brodde
January 1994, Journal of investigational allergology & clinical immunology,
N O'Hara, and O E Brodde
June 1986, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!